Oct 2026· IOASD Journal of Medical and Pharmaceutical Sciences· Vol 3, pp. 269· 0 citations· 13 references
TL;DR
Overall, isolongifolene and ICN-K04 showed protective effects against B(a)P-induced lung carcinogenesis under the experimental conditions.
Abstract
Benzo (a) pyrene (B(a)P) is a potent chemical carcinogen associated with lung carcinogenesis and cellular damage. The current research has demonstrated the effects of 5-Fluorouracil (5-FU), Chitosan Nanoparticles, Isolongifolene and ICN-K04. Animals were divided into Six groups: Control, B(a)P, B(a)P + 5-FU, Chitosan nanoparticles, Isolongifolene and ICN-K04. Body weight, Tumor incidence, Lung weight and Pulmonary ultrastructure were assessed. B(a)P-treated animals showed progressive body weight loss and 100% tumor incidence. Tumor incidence decreased to 37.5%, 75%, 25%, and 0% following 5-FU, chitosan nanoparticles, isolongifolene, and ICN-K04 treatment, respectively. Lung weight was significantly reduced in the 5-FU- and ICN-K04-treated groups. TEM analysis showed lipid accumulation, nuclear abnormalities, and mitochondrial swelling in B (a)P-treated animals. Isolongifolene and ICN-K04 treatment showed comparatively preserved cellular ultrastructure and reduced lipid accumulation. Overall, isolongifolene and ICN-K04 showed protective effects against B(a)P-induced lung carcinogenesis under the experimental conditions
Results established that supplementation with p-MCA and the reference drug (sorafenib) to NDEA induced rats significantly decreased the incidence of cancer in the liver, besides altering the phase I and phase II xenobiotic enzymes.
Sriragavi Ravi, Rajagopal Ayyanar, N. Namasivayam· Journal of Science & Tec...· 2 citations
Carica papaya
leaves (CPL), traditionally used in ethnomedicine to manage inflammatory conditions and as an adjuvant in therapies, have been reported to have anticancer potential. This study investigated the chemopreventive and immunomodulatory potentials of aqueous extract (AqCE) and flavonoid-rich extract (F...
Doris Olachi Alilonu, S. Elom, A. P. Ebokaiwe et al.· Journal of Cancer Research a...· 0 citations
Prostate cancer is the second most frequently diagnosed malignancy in men globally, with over 1.4 million new cases and approximately 397,430 deaths in 2022. Despite available treatments, incidence and mortality remain high, underscoring the need for novel, cost-effective therapeutic options. Myrianthus arboreus P. Bea...
Florette Tedjo Motoum, Sefirin Djiogue, Charline Florence Awounfack et al.· Integrative Cancer Therapies· 0 citations
Colon cancer (CC) is a leading cause of cancer-related mortality globally. Although chemotherapy remains the primary treatment, its toxicity and drug resistance highlight the need for alternative therapeutic strategies. Silymarin (Sily), a natural compound, and zinc oxide nanoparticles (ZnO-NPs) have shown potential an...
Eman H. Yousef, Aya Megahed, A. Samy et al.· Biomolecules· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.